3

PRIMARY DOCUMENT

Company: HALOZYME THERAPEUTICS, INC.
Filed: May 24, 2013
Period of Report: May 20, 2013
Accession Number: 0001483813-13-000072

View Document ↗ View on SEC.gov ↗